AQEMIA
Scale drug discovery with quantum-inspired physics and generative AI
84 employees · est. 2019 · Paris, France
PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs
14 employees · est. 2016 · Cambridge, United Kingdom
PharmEnable Therapeutics is the older company (2019 vs 2016); AQEMIA is the larger of the two.
Side-by-Side Comparison
| Metric | AQEMIA | PharmEnable Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2016 older |
| Headquarters | ||
| Headquarters | Paris, France | Cambridge, United Kingdom |
| Employees | ||
| Employees | 84 larger | 14 |
| Industry | ||
| Industry | AI, Biotechnology, Life Sciences | Biotechnology, Life Sciences, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Seed |
| Total Funding | ||
| Total Funding | $115.18M | $9.30M |
| Funding Rounds | ||
| Funding Rounds | 7 | 4 |
| Services | ||
| Services | AI-driven drug discovery, Development of next-generation medicines | AI-driven drug discovery, Development of small molecule drugs, Therapeutic target identification, Pipeline development |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech researchers, Healthcare providers | Pharmaceutical companies, Biotechnology firms, Medical researchers, Healthcare providers |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Quantum-inspired Physics, Generative AI, Pharmaceutical R&D, TechBio, PharmaTech, Computational Chemistry, Oncology, AI Drug Discovery, Drug Design, Physics-based Technology, Atomic Scale Physics, Biopharma, Immuno-Oncology | AI-enabled Drug Discovery, Small Molecule Drugs, Chemical Novelty, 3D Chemical Space Exploration, Oncology Therapeutics, Neurology Therapeutics, Proprietary AI Platform, ChemSEEK, Antibody-like Specificity, Drug Discovery Partnerships, University Of Cambridge Spinoff, Inaccessible Disease Targets |
| Website | ||
| Website | aqemia.com | pharmenabletx.com |
About AQEMIA
AQEMIA, founded in 2019, is a cutting-edge company at the intersection of AI and biotechnology, focusing on drug discovery through the use of quantum-inspired physics and generative AI. The company specializes in creating novel medicines to address significant diseases, particularly in the oncology...
About PharmEnable Therapeutics
PharmEnable Therapeutics, founded in 2016, is a pioneering biopharmaceutical company operating at the cutting edge of Biotechnology, Life Sciences, and Pharmaceutical industries. Based in the United Kingdom and a spin-off from the University of Cambridge, the company is renowned for its slogan: "Har...
We will tell you when either one moves
BounceWatch watches AQEMIA and PharmEnable Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AQEMIA and PharmEnable Therapeuti... — by email.
Frequently Asked Questions
Compare AQEMIA with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at AQEMIA on 15 Jun 2026, and PharmEnable Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.